HARMONY BIOSCIENCES HOLDINGS, INC. Stock Split Ratio
HARMONY BIOSCIENCES HOLDINGS, INC. (HRMY) reported Stock Split Ratio of 12.17% for the 1-month period ending 2020-08-31, per its 10-K filed 2023-02-21.
Discontinued › Notes › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2023-02-21
- 2020-08-31: Stockholders' Equity Note, Stock Split, Conversion Ratio 1 month 12.17%.
- 2020-08-11: Stockholders' Equity Note, Stock Split, Conversion Ratio 12.17%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio | Stockholders' Equity Note, Stock Split, Conversion Ratio 1 month |
|---|---|---|
| 2020-08-31 | 12.17% 10-K · filed 2023-02-21 | |
| 2020-08-11 | 12.17% 10-Q · filed 2021-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |